Use of whole genome sequencing to diagnose a cryptic fusion oncogene

CONTEXT: Whole genome sequencing (WGS) is becoming increasingly available for research purposes, but it has not yet been routinely used for clinical diagnosis. OBJECT: To determine whether whole genome sequencing can identify cryptic, actionable mutations in a clinically relevant time frame. DESIGN,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Welch, John S., Westervelt, Peter, Ding, Li, Larson, David E., Klco, Jeffery M., Kulkarni, Shashikant, Wallis, John, Chen, Ken, Payton, Jacqueline E., Fulton, Robert S., Veizer, Joelle, Schmidt, Heather, Vickery, Tammi L., Heath, Sharon, Watson, Mark A., Tomasson, Michael H., Link, Daniel C., Graubert, Timothy A., DiPersio, John F., Mardis, Elaine R., Ley, Timothy J., Wilson, Richard K.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156695/
https://ncbi.nlm.nih.gov/pubmed/21505136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.497
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares